Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Tumor hypoxia imaging.

Sun X, Niu G, Chan N, Shen B, Chen X.

Mol Imaging Biol. 2011 Jun;13(3):399-410. doi: 10.1007/s11307-010-0420-z.

PMID:
20838906
2.

Functional imaging of cancer with emphasis on molecular techniques.

Torigian DA, Huang SS, Houseni M, Alavi A.

CA Cancer J Clin. 2007 Jul-Aug;57(4):206-24. Review. Erratum in: CA Cancer J Clin. 2007 Nov-Dec;57(6):380.

PMID:
17626118
3.

Non-invasive imaging for studying anti-angiogenic therapy effects.

Ehling J, Lammers T, Kiessling F.

Thromb Haemost. 2013 Mar;109(3):375-90. doi: 10.1160/TH12-10-0721. Epub 2013 Feb 14.

4.

Molecular imaging of hypoxia with radiolabelled agents.

Mees G, Dierckx R, Vangestel C, Van de Wiele C.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1674-86. doi: 10.1007/s00259-009-1195-9. Epub 2009 Jun 30. Review.

5.

Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.

6.

Options for visualizing metastatic disease in the living body.

Helms MW, Brandt BH, Contag CH.

Contrib Microbiol. 2006;13:209-31. Review.

PMID:
16627968
7.

Functional imaging of intratumoral hypoxia.

Foo SS, Abbott DF, Lawrentschuk N, Scott AM.

Mol Imaging Biol. 2004 Sep-Oct;6(5):291-305. Review.

PMID:
15380739
8.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.

9.

Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.

Yip C, Cook GJ, Wee J, Fong KW, Tan T, Goh V.

Chin Clin Oncol. 2016 Apr;5(2):24. doi: 10.21037/cco.2016.03.16. Review.

10.

Oncologic imaging end-points for the assessment of therapy response.

Serkova NJ, Garg K, Bradshaw-Pierce EL.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):36-53. Review.

PMID:
19149687
11.

Non-invasive Imaging in Gene Therapy.

Räty JK, Liimatainen T, Unelma Kaikkonen M, Gröhn O, Airenne KJ, Ylä-Herttuala S.

Mol Ther. 2007 Sep;15(9):1579-86. Epub 2007 Jun 19. Review. Erratum in: Mol Ther. 2007 Nov;15(11):2052. Jumani Airenne, Kari [corrected to Airenne, Kari Juhani].

12.

Imaging Agents in Targeting Tumor Hypoxia.

Zeng Y, Ma J, Zhang S, Wu D.

Curr Med Chem. 2016;23(17):1775-800. Review.

PMID:
26997152
13.

Recent advances on radionuclide labeled hypoxia-imaging agents.

Li Z, Chu T.

Curr Pharm Des. 2012;18(8):1084-97. Review.

PMID:
22272826
14.

Noninvasive imaging of transplanted cells.

Modo M.

Curr Opin Organ Transplant. 2008 Dec;13(6):654-8. doi: 10.1097/MOT.0b013e328317a43c. Review.

PMID:
19060558
15.

Noninvasive imaging of tumor burden and molecular pathways in mouse models of cancer.

Wang Y, Tseng JC, Sun Y, Beck AH, Kung AL.

Cold Spring Harb Protoc. 2015 Feb 2;2015(2):135-44. doi: 10.1101/pdb.top069930. Review.

PMID:
25646505
16.

Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Holland JP, Lewis JS, Dehdashti F.

Q J Nucl Med Mol Imaging. 2009 Apr;53(2):193-200. Review.

17.

Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Waerzeggers Y, Ullrich RT, Monfared P, Viel T, Weckesser M, Stummer W, Schober O, Winkeler A, Jacobs AH.

Br J Radiol. 2011 Dec;84 Spec No 2:S179-95. doi: 10.1259/bjr/76389842. Review.

18.

Hypoxia imaging markers and applications for radiation treatment planning.

Lin A, Hahn SM.

Semin Nucl Med. 2012 Sep;42(5):343-52. doi: 10.1053/j.semnuclmed.2012.04.002. Review.

PMID:
22840599
19.

In vivo imaging of cellular transplants.

Chan J, Menon JP, Mahajan R, Jandial R.

Adv Exp Med Biol. 2010;671:1-12. Review.

PMID:
20455491
20.

New technologies for human cancer imaging.

Frangioni JV.

J Clin Oncol. 2008 Aug 20;26(24):4012-21. doi: 10.1200/JCO.2007.14.3065. Review.

Supplemental Content

Support Center